The respiratory inhalers market is expected to grow from US$ 31,144.56 million in 2022 to US$ 43,446.19 million by 2028; it is estimated to record a CAGR of 5.7% from 2022 to 2028.
Respiratory inhalers are used to inhale drugs that are an essential part of treating chronic lung diseases. They are used both to prevent and treat exacerbations of these chronic diseases. They offer the advantage of avoiding systemic drug exposure while ensuring the drugs reach the lungs directly. Numerous products deliver drugs directly into the airways, such as dry powder inhalers, metered dose inhalers (MDIs), nebulizers, and soft mist inhalers. The respiratory inhalers market is expected to grow due to the rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, asthma-COPD overlap syndrome, and others.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Respiratory Inhalers Market: Strategic Insights
Market Size Value in US$ 31,144.56 million in 2022 Market Size Value by US$ 43,446.19 million by 2028 Growth rate CAGR of 5.7% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Respiratory Inhalers Market: Strategic Insights
| Market Size Value in | US$ 31,144.56 million in 2022 |
| Market Size Value by | US$ 43,446.19 million by 2028 |
| Growth rate | CAGR of 5.7% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Respiratory Inhalers Market Insights
Growing Adoption of Generic Inhalers Drives Growth of Respiratory Inhalers Market
Inhaled medicines involving a wide range of inhalation devices are the mainstay of pharmacological treatment of asthma and COPD. Patients suffering from asthma and COPD often need one or more inhalers daily to keep their airways healthy. Therefore, healthcare professionals are concerned about switching between medications as it can negatively impact disease control through low adherence and misuse of aerosol delivery device types. With increasing pressure on healthcare budgets and the simultaneous expiration of patents on established inhalation treatments, several generic replacement products are being manufactured and supplied across the globe. Several inhalants that are used to treat asthma include generic formulations, such as albuterol, levalbuterol, ipratropium, budesonide, and fluticasone/salmeterol. The generic inhalers are bioequivalent to the branded versions and have the same effect on the body. The number of generic asthma inhalers continues to increase as patents expire. On March 3, 2020, the Food and Drug Administration (FDA) cleared generic asthma inhalers and generic inhaled corticosteroid powder. In April 2020, the FDA approved a generic inhaler, based on albuterol sulfate, to cater to the needs of COVID-19 patients having breathing difficulties. As more generic drugs are entering the market, increased competition is expected, which, in turn, leads to reduced costs of drugs. Cost reductions can also result from the launch of an “approved generic drug.” Thus, the growing adoption of generic inhalers and asthma medications is improving medication adherence, thereby driving the respiratory inhalers market
Product Type-Based Insights
Based on product type, the respiratory inhalers market is segmented into nebulizers, metered dose inhalers, and dry powder inhalers. The dry powder inhalers segment is further bifurcated into multi-dose dry powder inhalers and single-dose dry powder inhalers. The metered dose inhalers (MDI) segment is further divided into pressured metered dose inhalers and connected metered dose inhalers. The nebulizers segment is sub segmented into compressed air nebulizers, mesh air nebulizers, and ultrasonic air nebulizers. In 2022, the dry powder inhalers segment accounted for the largest market share. However, the metered dose inhalers (MDI) segment is anticipated to register the highest CAGR during the forecast period.
Respiratory Inhalers Market, by Product Type– 2022 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Technology-Based Insights
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on technology, the respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held a larger market share in 2022 and is expected to register a higher CAGR during the forecast period.
Disease Indication-Based Insights
Based on disease indication, the global respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. The asthma segment held the largest share of the market in 2022 and is expected to grow at the highest CAGR during the forecast period.
Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the respiratory inhalers market. A few recent key market developments are listed below:
- In September 2022, Beximco Pharmaceuticals launched ONRIVA TRIO BEXICAP, which is a dry inhaler capsule. ONRIVA TRIO BEXICAP is the preparation of Indacaterol (150 µg), Glycopyrronium (50 µg), and Mometasone (160 µg). It works in 3 ways to control asthma symptoms. Indacaterol and Glycopyrronium help the muscles of lung airways to stay relaxed to prevent bronchoconstriction, while Mometasone helps to decrease inflammation. ONRIVA TRIO BEXICAP is indicated as maintenance therapy in severe persistent asthma.
- In June 2021, Cipla announced that it had received final approval for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL from the US Food and Drug Administration. Cipla's Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is an AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.'s Brovana.
- In February 2022, AstraZeneca and Honeywell announced their plans to partner for the development of next-generation respiratory inhalers using the propellant HFO-1234ze, which has up to 99.9% less Global Warming Potential (GWP) than propellants currently used in respiratory medicines.
- In January 2023, FDA approved Airsupra [pressurized metered-dose inhaler (pMDI)] in the US for the as-needed treatment or prevention of bronchoconstriction. Airsupra is a first-in-class, pressurized metered-dose inhaler (pMDI), fixed-dose combination rescue medication containing albuterol, a short-acting beta2-agonist (SABA), and budesonide, an anti-inflammatory inhaled corticosteroid (ICS) in the US.
Company Profiles
- AstraZeneca Plc
- Beximco Pharmaceuticals Ltd.
- Boehringer Ingelheim International GmbH
- Cipla Ltd.
- GSK Plc
- Koninklijke Philips NV
- OMRON Corp
- PARI Respiratory Equipment, Inc.
- Teva Pharmaceutical Industries Ltd.
- OPKO Health, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type, Technology, and Disease Indication
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Respiratory inhalers are used to inhale drugs that are an essential part of treating chronic lung diseases. They are used both to prevent and treat exacerbations of these chronic diseases. They offer the advantage of avoiding systemic drug exposure while ensuring the drugs reach the lungs directly. Numerous products deliver drugs directly into the airways, such as dry powder inhalers, metered dose inhalers (MDIs), nebulizers and soft mist inhalers. The respiratory inhaler market is expected to flourish due to the rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, asthma-COPD overlap syndrome, and others.
Key factors driving the market growth are rising cases of respiratory disorders and growing adoption of generic inhalers.
The respiratory inhalers market, by product type, is segmented into nebulizers, metered dose inhalers, and dry powder inhalers. The dry powder inhalers segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period (2022–2028).
Based on technology, the global respiratory inhalers market is divided into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held the largest share of the market in 2022 and is expected to grow at the highest CAGR during the forecast period.
Companies operating in the market are AstraZeneca Plc, Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH, Cipla Ltd.;GSK Plc, Koninklijke Philips NV, OMRON Corp, PARI Respiratory Equipment, Inc.; Teva Pharmaceutical Industries Ltd.; and OPKO Health, Inc..
Global respiratory inhalers market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the respiratory inhalers market during 2022–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Respiratory Inhalers Market – by Product Type
1.3.2 Global Respiratory Inhalers Market – by Technology
1.3.3 Global Respiratory Inhalers Market – by Disease Indication
1.3.4 Global Respiratory Inhalers Market – by Geography
2. Respiratory Inhalers Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Respiratory Inhalers Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Respiratory Inhalers Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Cases of Respiratory Disorders
5.1.2 Growing Adoption of Generic Inhalers
5.2 Market Restraints
5.2.1 Lack of Early Diagnosis and High Cost of Inhalers
5.3 Market Opportunities
5.3.1 Increasing Adoption of Smart Inhalers Technology
5.4 Future Trends
5.4.1 Increasing Product Development Activities
5.5 Impact Analysis
6. Respiratory Inhalers Market – Global Analysis
6.1 Global Respiratory Inhalers Market Revenue Forecast and Analysis
6.2 Global Respiratory Inhalers Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Respiratory Inhalers Market – Revenue and Forecast to 2028 – by Product Type
7.1 Overview
7.2 Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
7.3 Dry Powder Inhalers
7.3.1 Overview
7.3.2 Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Multi-Dose Dry Powder Inhalers
7.3.3.1 Overview
7.3.3.2 Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Single Dose Dry Powder Inhalers
7.3.4.1 Overview
7.3.4.2 Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Metered Dose Inhalers
7.4.1 Overview
7.4.2 Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Pressured Metered Dose Inhalers
7.4.3.1 Overview
7.4.3.2 Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Connected Metered Dose Inhalers
7.4.4.1 Overview
7.4.4.2 Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Nebulizers
7.5.1 Overview
7.5.2 Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Compressed Air Nebulizers
7.5.3.1 Overview
7.5.3.2 Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Mesh Air Nebulizers
7.5.4.1 Overview
7.5.4.2 Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Ultrasonic Air Nebulizers
7.5.5.1 Overview
7.5.5.2 Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Respiratory Inhalers Market Analysis and Forecast to 2028 – by Technology
8.1 Overview
8.2 Global Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
8.3 Manually Operated Inhalers
8.3.1 Overview
8.3.2 Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Digitally Operated Inhalers
8.4.1 Overview
8.4.2 Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9. Global Respiratory Inhalers Market Analysis and Forecast to 2028 – by Disease Indication
9.1 Overview
9.2 Global Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
9.3 Asthma
9.3.1 Overview
9.3.2 Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 COPD
9.4.1 Overview
9.4.2 COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pulmonary Arterial Hypertension
9.5.1 Overview
9.5.2 Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10. Respiratory Inhalers Market – Revenue and Forecast to 2028 – Geographic Analysis
10.1 North America: Respiratory Inhalers Market
10.1.1 Overview
10.1.2 North America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.3.1 North America: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.3.2 North America: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.3.3 North America: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.4 North America: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.5 North America: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.6 North America: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.7 US: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.8 US: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.8.1 US: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.8.2 US: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.8.3 US: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.9 US: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.10 US: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.10.1 Canada: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.10.1.1 Overview
10.1.10.1.2 Canada: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.10.1.3 Canada: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.10.1.3.1 Canada: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.10.1.3.2 Canada: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.10.1.3.3 Canada: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.10.1.4 Canada: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.10.1.5 Canada: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.10.2 Mexico: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.10.2.1 Overview
10.1.10.2.2 Mexico: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.10.2.3 Mexico: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.10.2.3.1 Mexico: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.10.2.3.2 Mexico: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.10.2.3.3 Mexico: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.10.2.4 Mexico: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.10.2.5 Mexico: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.2 Europe: Respiratory Inhalers Market
10.2.1 Overview
10.2.2 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.3 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.3.1 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.3.2 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.3.3 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.4 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.5 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.2.6 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Country (%)
10.2.6.1 UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.1.1 Overview
10.2.6.1.2 UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.1.3 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.6.1.3.1 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.6.1.3.2 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.6.1.3.3 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.6.1.4 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.6.1.5 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.2.6.2 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.2.1 Overview
10.2.6.2.2 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.2.3 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.6.2.3.1 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.6.2.3.2 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.6.2.3.3 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.6.2.4 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.6.2.5 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.2.6.3 France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.3.1 Overview
10.2.6.3.2 France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.3.3 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.6.3.3.1 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.6.3.3.2 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.6.3.3.3 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.6.3.4 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.6.3.5 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.2.6.4 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.4.1 Overview
10.2.6.4.2 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.4.3 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.6.4.3.1 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.6.4.3.2 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.6.4.3.3 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.6.4.4 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.6.4.5 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.2.6.5 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.5.1 Overview
10.2.6.5.2 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.5.3 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.6.5.3.1 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.6.5.3.2 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.6.5.3.3 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.6.5.4 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.6.5.5 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.2.6.6 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.6.3 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.6.6.3.1 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.6.6.3.2 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.6.6.3.3 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.6.6.4 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.6.6.5 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.3 Asia Pacific: Respiratory Inhalers Market
10.3.1 Overview
10.3.2 Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.3.1 Asia Pacific: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.3.2 Asia Pacific: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.3.3 Asia Pacific: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.4 Asia Pacific: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.5 Asia Pacific: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.3.6 Asia Pacific: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 China: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.6.1.3.1 China: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.6.1.3.2 China: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.6.1.3.3 China: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.6.1.4 China: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.6.1.5 China Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.3.6.2 Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 Japan: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.6.2.3.1 Japan: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.6.2.3.2 Japan: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.6.2.3.3 Japan: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.6.2.4 Japan: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.6.2.5 Japan: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.3.6.3 India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.6.3.3.1 India: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.6.3.3.2 India: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.6.3.3.3 India: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.6.3.4 India: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.6.3.5 India: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.3.6.4 Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 Australia: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.6.4.3.1 Australia: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.6.4.3.2 Australia: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.6.4.3.3 Australia: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.6.4.4 Australia: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.6.4.5 Australia: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.3.6.5 South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 South Korea: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.6.5.3.1 South Korea: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.6.5.3.2 South Korea: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.6.5.3.3 South Korea: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.6.5.4 South Korea: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.6.5.5 South Korea: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.6.6.3.1 Rest of Asia Pacific: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.6.6.3.2 Rest of Asia Pacific: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.6.6.3.3 Rest of Asia Pacific: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.4 Middle East & Africa Respiratory Inhalers Market
10.4.1 Overview
10.4.2 Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.4.3.1 Middle East & Africa: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.4.3.2 Middle East & Africa: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.4.3.3 Middle East & Africa: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.4.4 Middle East & Africa: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.4.5 Middle East & Africa Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.4.6 Middle East & Africa: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.4.6.1 Saudi Arabia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 Saudi Arabia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 Saudi Arabia: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.4.6.1.3.1 Saudi Arabia: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.4.6.1.3.2 Saudi Arabia: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.4.6.1.3.3 Saudi Arabia: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.4.6.1.4 Saudi Arabia: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.4.6.1.5 Saudi Arabia Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.4.6.2 South Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 South Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 South Africa: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.4.6.2.3.1 South Africa: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.4.6.2.3.2 South Africa: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.4.6.2.3.3 South Africa: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.4.6.2.4 South Africa: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.4.6.2.5 South Africa Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.4.6.3 UAE: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 UAE: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 UAE: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.4.6.3.3.1 UAE: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.4.6.3.3.2 UAE: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.4.6.3.3.3 UAE: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.4.6.3.4 UAE: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.4.6.3.5 UAE Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.4.6.4 Rest of Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.4.6.4.3.1 Rest of Middle East & Africa: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.4.6.4.3.2 Rest of Middle East & Africa: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.4.6.4.3.3 Rest of Middle East & Africa: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.4.6.4.5 Rest of Middle East & Africa Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.5 South & Central America Respiratory Inhalers Market
10.5.1 Overview
10.5.2 South & Central America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.3 South & Central America: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.5.3.1 South & Central America: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.5.3.2 South & Central America: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.5.3.3 South & Central America: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.5.4 South & Central America: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.5.5 South & Central America: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.5.6 South & Central America: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 Brazil: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.5.6.1.3.1 Brazil: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.5.6.1.3.2 Brazil: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.5.6.1.3.3 Brazil: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.5.6.1.4 Brazil: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.5.6.1.5 Brazil: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.5.6.2 Argentina: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Argentina: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Argentina: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.5.6.2.3.1 Argentina: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.5.6.2.3.2 Argentina: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.5.6.2.3.3 Argentina: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.5.6.2.4 Argentina: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.5.6.2.5 Argentina: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.5.6.3 Rest of South & Central America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South & Central America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 Rest of South & Central America: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.5.6.3.3.1 Rest of South & Central America: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.5.6.3.3.2 Rest of South & Central America: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.5.6.3.3.3 Rest of South & Central America: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.5.6.3.5 Rest of South & Central America: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
11. Impact of COVID-19 Pandemic on Respiratory Inhalers Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.5 South & Central America: Impact Assessment of COVID-19 Pandemic
12. Global Respiratory Inhalers Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Respiratory Inhalers Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 AstraZeneca Plc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Beximco Pharmaceuticals Ltd.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Boehringer Ingelheim International GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Cipla Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 GSK Plc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Koninklijke Philips NV
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 OMRON Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 PARI Respiratory Equipment, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Teva Pharmaceutical Industries Ltd
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 OPKO Health, Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 6. North America Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 8. US Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 10. US Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 11. US Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 12. US Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 17. Canada Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 18. Canada Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 21. Mexico Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 22. Mexico Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 23. Mexico Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 24. Mexico Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. Europe Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 27. Europe Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 28. Europe Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 29. Europe Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 30. Europe Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 31. UK Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 33. UK Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 34. UK Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 35. UK Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 36. UK Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 37. Germany Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. Germany Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 39. Germany Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 40. Germany Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 41. Germany Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 42. Germany Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 43. France Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 44. France Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 45. France Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 46. France Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 47. France Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 48. France Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 49. Italy Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 50. Italy Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 51. Italy Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 52. Italy Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 53. Italy Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 54. Italy Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 55. Spain Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 56. Spain Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 57. Spain Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 58. Spain Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 59. Spain Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 60. Spain Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 61. Rest of Europe Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 62. Rest of Europe Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 63. Rest of Europe Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 64. Rest of Europe Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 65. Rest of Europe Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 66. Rest of Europe Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 67. Asia Pacific Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 68. Asia Pacific Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 69. Asia Pacific Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 70. Asia Pacific Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 71. Asia Pacific Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 72. Asia Pacific Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 73. China Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 74. China Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 75. China Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 76. China Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 77. China Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 78. China Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 79. Japan Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 80. Japan Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 81. Japan Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 82. Japan Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 83. Japan Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 84. Japan Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 85. India Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 86. India Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 87. India Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 88. India Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 89. India Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 90. India Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 91. Australia Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 92. Australia Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 93. Australia Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 94. Australia Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 95. Australia Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 96. Australia Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 97. South Korea Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 98. South Korea Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 99. South Korea Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 100. South Korea Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 101. South Korea Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 102. South Korea Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 103. Rest of Asia Pacific Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 104. Rest of Asia Pacific Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 105. Rest of Asia Pacific Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 106. Rest of Asia Pacific Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of Asia Pacific Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of Asia Pacific Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 109. Middle East & Africa Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 110. Middle East & Africa Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 111. Middle East & Africa Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 112. Middle East & Africa Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 113. Middle East & Africa Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 114. Middle East & Africa Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 115. Saudi Arabia Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 116. Saudi Arabia Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 117. Saudi Arabia Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 118. Saudi Arabia Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 119. Saudi Arabia Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 120. Saudi Arabia Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 121. South Africa Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 122. South Africa Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 123. South Africa Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 124. South Africa Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 125. South Africa Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 126. South Africa Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 127. UAE Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 128. UAE Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 129. UAE Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 130. UAE Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 131. UAE Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 132. UAE Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 133. Rest of Middle East & Africa Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 134. Rest of Middle East & Africa Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 135. Rest of Middle East & Africa Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 136. Rest of Middle East & Africa Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 137. Rest of Middle East & Africa Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 138. Rest of Middle East & Africa Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 139. South & Central America Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 140. South & Central America Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 141. South & Central America Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 142. South & Central America Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 143. South & Central America Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 144. South & Central America Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 145. Brazil Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 146. Brazil Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 147. Brazil Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 148. Brazil Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 149. Brazil Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 150. Brazil Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 151. Argentina Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 152. Argentina Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 153. Argentina Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 154. Argentina Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 155. Argentina Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 156. Argentina Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 157. Rest of South & Central America Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 158. Rest of South & Central America Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 159. Rest of South & Central America Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 160. Rest of South & Central America Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 161. Rest of South & Central America Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 162. Rest of South & Central America Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 163. Recent Inorganic Growth Strategies in the Respiratory Inhalers Market
Table 164. Recent Organic Growth Strategies in the Respiratory Inhalers Market
Table 165. Glossary of Terms
LIST OF FIGURES
Figure 1. Respiratory Inhalers Market Segmentation
Figure 2. Respiratory Inhalers Market, by Region
Figure 3. Global Respiratory Inhalers Market Overview
Figure 4. Dry Powder Inhalers Segment Held Largest Share of Product Type Segment in Respiratory Inhalers Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Respiratory Inhalers Market, by Geography (US$ Million)
Figure 7. Global Respiratory Inhalers Market – Leading Country Markets (US$ Million)
Figure 8. Global Respiratory Inhalers Market – Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Middle East & Africa: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Respiratory Inhalers Market – Revenue Forecast and Analysis – 2020–2028
Figure 17. Global Respiratory Inhalers Market, by Geography – Forecast and Analysis (2021–2028)
Figure 18. Market Positioning of Key Players in Respiratory Inhalers Market
Figure 19. Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
Figure 20. Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Global Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
Figure 31. Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Global Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
Figure 34. Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. North America: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 39. North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. US: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Canada: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Mexico: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Europe Respiratory Inhalers Market Revenue overview, by Country, 2021 (US$ MN)
Figure 44. Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 45. Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Country (%)
Figure 46. UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 47. Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 48. France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 49. Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 50. Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 51. Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 52. Asia Pacific: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 53. Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. Middle East & Africa: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 61. Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. Saudi Arabia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. South Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. UAE: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. Rest of Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. South & Central America: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 67. South & Central America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. South & Central America: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
Figure 69. Brazil: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 70. Argentina: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 71. Rest of South & Central America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 72. Impact of COVID-19 Pandemic on North American Country Markets
Figure 73. Impact of COVID-19 Pandemic on Respiratory Inhalers Market in European Countries
Figure 74. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 75. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 76. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 77. Growth Strategies in the Respiratory Inhalers Market
The List of Companies - Respiratory Inhalers Market
- AstraZeneca Plc
- Beximco Pharmaceuticals Ltd.
- Boehringer Ingelheim International GmbH
- Cipla Ltd.
- GSK Plc
- Koninklijke Philips NV
- OMRON Corp
- PARI Respiratory Equipment, Inc.
- Teva Pharmaceutical Industries Ltd.
- OPKO Health, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Respiratory Inhalers Market
Mar 2023
Digital PCR (dPCR) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology [Droplet Digital PCR (ddPCR) and BEAMing Digital PCR], Component (Instruments, Reagents and Consumables, and Software and Services), Application (Clinical, Research, and Forensic), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organization), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2023
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Mar 2023
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2023
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2023
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2023
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2023
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2023
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography